Multi-cancer early detection is a groundbreaking new type of cancer screening test that utilizes advances in genomic science and machine learning to transform cancer detection. Over 400 organizations are advocating to ensure access for seniors.
When it comes to cancer, we need time on our side. Finding cancer early leads to more effective, efficient treatment and a better quality of life for patients and their loved ones.
Today, routine screening is available for only five types of cancer, which leaves the vast majority of cancers without available screening tests. But when cancer is detected early, nine of every 10 cancer patients will live five years or longer.
The Prevent Cancer Foundation and more than 400 cancer advocacy organizations are advocating to ensure increased access to multi-cancer screening tests once they are shown to have clinical benefit and approved by the FDA.